We are pleased to inform you that accepted abstracts, submitted by registered participants, will have the privilege of being published in the esteemed journal Metabolism, providing a valuable platform for sharing your research findings with the scientific community. Your work will reach a broad audience, making a significant impact in the field and fostering collaborations for future research.

 

Accepted abstracts will have the opportunity to present their work in the Abstract Hall, facilitating fruitful discussions and knowledge exchange during the event. Following this, our abstract committee will select the top 6 abstracts for the Abstract Oral Presentation Session during the conference, offering researchers an additional platform to showcase their groundbreaking work. In special cases, we may consider Late Breaking Abstracts for the oral presentation session. However, we strongly recommend early submission as it increases your chances of securing a spot among the top selections. Late Breaking submissions will fill only 2 out of 6 slots, whereas submitting early provides a chance for you to secure one of the first 4 slots.

​

To recognize excellence in research, the top abstracts will receive prestigious awards and cash prizes at the Gold, Silver, Bronze, and Honorable Mention levels, motivating scholars to continue contributing to the advancement of knowledge in this field.

​

 

For any inquiries or further information, please do not hesitate to contact us at jcj@tmioa.com. We are here to assist and support you in making your participation at the event a rewarding experience. Thank you for your dedication to scientific advancement, and we look forward to your active involvement at the conference.

​

View a sample abstract submission from the PDF below:

​

​

​

 

​

          

​

​

​

Abstract Submission & Topics:

Clinical Aspects of Insulin Resistance Across Lifespan: Explore insulin resistance's clinical dimensions in childhood, adolescence, and adulthood, encompassing domains such as diabetes, obesity, dyslipidemia, hypertension, cardiovascular disease, malignancy, liver disease, renal dysfunction, gonadal anomalies, and sleep disorders including obstructive sleep apnea.

​

Basic science:

Investigate mechanisms underlying insulin resistance, inflammation, endothelial and vascular anomalies, and metabolic dysfunction in pivotal centers like the beta cell, adipocyte, gut, and brain.

​

Special Notice:

All abstracts submitted are being checked for plagiarism and AI generated material. Of note, the software is able to identify plagiarism based on all international journals. Abstracts that will be identified as such, will not be published and the authors will be barred from future submission. 

 

Guidelines:

Submitted abstracts should focus on clinical or basic science aspects of insulin resistance, extending to areas like diabetes, obesity, and cardiovascular disease. Investigating overall pathophysiology and effects on key metabolic centers (e.g., beta cell, adipocyte, gut, brain), as well as studies related to inflammation and endothelial

or vascular anomalies, are of interest. Clinical topics can span insulin resistance's role in conditions such as obesity, diabetes, hypertension, dyslipidemia, cardiovascular disease, renal dysfunction, gonadal irregularities (including PCOS and male hypogonadism), gestational diabetes, other endocrine disorders, liver disease (NAFLD), malignancy, and sleep disorders like obstructive sleep apnea.

​

WCIRDC is also keen on exploring multi-hormonal aspects of obesity, gut hormonal contributions (including incretins) to energy balance, and the influence of circadian rhythms on metabolic mechanisms. Basic science studies should feature a specific link to insulin action and its regulation at the cellular, organ, or whole-body levels. To align with these guidelines, authors are encouraged to provide a brief explanation of how their topic relates to insulin resistance and/or the aforementioned metabolic processes.

​

Abstract Submission & Topics: Abstracts should focus on clinical or basic science aspects of insulin resistance in fields such as diabetes, obesity, and cardiovascular disease. Investigations of pathophysiology and effects on key metabolic centers, such as the beta cell, adipocyte, gut, and brain, are of particular interest. Studies related to inflammation, endothelial or other vascular dysfunction and multi-hormonal aspects of obesity will also be considered. Clinical topics may encompass insulin resistance in relation to obesity, diabetes, hypertension, dyslipidemia, cardiovascular disease, renal disease, gonadal dysfunction, liver disease (NAFLD), malignancy, and sleep disorders such as obstructive sleep apnea.

Abstract Oral Presentations: Six of the highest-ranking abstracts will be chosen for the Abstract Oral Presentation Session. Authors of winning abstracts will present their research findings in a 10-minute presentation, followed by a 5-minute Q&A session. If selected, authors are required to register for the meeting and prepare a PowerPoint presentation.

Top Abstract Awards: The highest-ranking abstracts will receive awards at different levels: Gold, Silver, Bronze, and honorable mentions. Award recipients will be chosen from the Abstract Oral Winners.

Abstract Poster Presentations: Accepted abstracts may be presented as posters at the conference. Authors or presenters for poster presentations must be registered participants. The presenter must be one of the authors listed on the abstract. Groups or companies with more than one abstract must assign a separate presenter for each poster presentation.

Eligibility for Publication: To be eligible for publication, at least one author of the accepted abstract must be a registered participant of the 23rd WCIRDC and must have presented the abstract in person at the conference.  Authors of all accepted abstracts will receive a 50% reimbursement on the regular general admission registration fee upon in-person attendance and presentation.    This registration includes full access to on-demand content for 90 days. To qualify for the reimbursement, you must attend the meeting in person and present your poster. Reimbursements are offered exclusively to those who meet this requirement. To request your reimbursement after the conference, please email: JC Javellana  jcj@tmioa.com.

Encore abstracts are accepted under special circumstances. Make sure to identify your abstract as an encore if it was published or presented in a different conference. Please note that Encore abstracts will not be published under Metabolism and will not be eligible for oral abstract presentations or awards.  In addition, upon acceptance of your encore abstract, at least one of the authors should be registered for the conference and is present on-site to present their posters during the meeting.

Important Information

• foabstracts is from June 10, 2025 to November 3, 20

• Deadline for submission is November 3, 2025 at 11:59 PM, Pacific Standard Time. 

• 
  A maximum of three abstract submissions will be accepted per group, individual submitter, or company.

• Authors may be listed on multiple abstracts.

• 
  Abstracts and scientific material presented at the conference must not have been published or presented prior to December 4, 2025.

• 
  Abstracts must be submitted electronically and should not exceed 250 words. Tables, graphs, figures, or references should not be included.

• 
  All materials must arrive on or before the abstract deadline noted.

• 
  Abstracts will be graded by the scientific planning committee, The International Committee for Insulin Resistance.

• 
  Poster guidelines, including presentation size and layout details, can be found at wcir.org/poster-guidelines.

• If an author wishes to make changes or withdraw their abstract, they must notify the WCIRDC team no later than November 24, 2025. Requests submitted after this date may not be accommodated.